What Key Growth Drivers Are Shaping The Generic Musculoskeletal Disorders Drugs Market Forecast Toward $0.08 Billion?
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
What Is The Predicted Market Size Of The Generic Musculoskeletal Disorders Drugs Industry By 2029?
In recent times, there has been a robust growth in the market size of generic drugs for musculoskeletal disorders. The market is predicted to expand from a value of $0.06 billion in 2024 to an equivalent value in 2025, but with a Compound Annual Growth Rate (CAGR) of 5.7%. The reasons for the growth witnessed in the historic period can be traced back to the prevalence of musculoskeletal disorders, the regulatory landscape, the development of healthcare infrastructure, patient awareness and education, as well as various economic factors.
Expectations are solid for substantial growth in the generic musculoskeletal disorders drugs market in the coming years. The projected size of the market is expected to reach $0.08 billion by 2029, showing a compound annual growth rate (CAGR) of 6.9%. This forthcoming growth during the forecast period can be linked to factors like increase in population and aging, developing markets, precision medicine, personalized therapies, reforms in healthcare, and global health patterns. The forecast period also reveals significant trends including technological inclusion in treatment, government-driven initiatives and health policies, a shift towards alternatives for pain management, a rise in the embrace of biosimilars, and advancements seen within the development of generic drugs.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9433&type=smp
What Underlying Factors Are Supporting The Generic Musculoskeletal Disorders Drugs Market Growth?
The widespread occurrence of arthritis is anticipated to boost the expansion of the generic musculoskeletal disorders drugs market. Arthritis, characterized by joint tenderness and swelling, alongside symptoms of joint pain and stiffness, is usually treated with generic musculoskeletal disorders drugs. These drugs alleviate muscle pain and stiffness, and can also treat muscle spasms in arthritis sufferers. As per data from Versus Arthritis, a UK-based charity, in March 2022, approximately 10 million people in the UK have been diagnosed with osteoarthritis. This includes 5.4 million with knee OA, 3.2 million with hip OA, around 450,000 with rheumatoid arthritis, and 190,000 with psoriatic arthritis. These figures indicate over 20 million people endure musculoskeletal conditions, resulting in over 30 million prescriptions for such ailments. The cost of these prescriptions in 2022-2023 is expected to be around £139 million. Hence, the widespread occurrence of arthritis is fuelling the demand in the generic musculoskeletal disorders drugs market.
Which Segments Define The Structure Of The Generic Musculoskeletal Disorders Drugs Market?
The generic musculoskeletal disorders drugs market covered in this report is segmented –
1) By Treatment Type: Medication, Therapy, Surgery, Other Treatment Types
2) By Disorder Type: Osteoarthritis, Rheumatoid Arthritis, Spondylarthritis, Juvenile Idiopathic Arthritis, Psoriatic Arthritis, Fibromyalgia, Other Disorder Types
3) By Route Of Administration: Oral, Parenteral, Other Routes
4) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Drug Store, Online Pharmacy
Subsegments:
1) By Medication: Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), Analgesics, Corticosteroids, Disease-Modifying Antirheumatic Drugs (DMARDs), Biologics
2) By Therapy: Physical Therapy, Occupational Therapy, Chiropractic Treatment, Massage Therapy
3) By Surgery: Joint Replacement Surgery, Arthroscopy, Spinal Surgery, Fusion Surgery
4) By Other Treatment Types: Lifestyle Modifications, Alternative Therapies, Assistive Devices
What Strategic Shifts And Innovations Are Influencing The Generic Musculoskeletal Disorders Drugs Market?
The rise in strategic alliances is a noteworthy trend making waves in the generic musculoskeletal disorders drugs market. Numerous corporations are entering partnerships to reinforce their standing in the industry. For example, in July 2022, a collaboration was announced between the Japan-based Mitsubishi Tanabe Pharma Corporation and the US-based Eli Lilly and Company. This alliance allows each company to enhance their product range and provide patients with effective solutions for diabetes and various other diseases. Moreover, Pfizer Inc., an American pharmaceutical company, formed a strategic collaboration with Alex Therapeutics, a digital therapeutics enterprise from Sweden, in February 2022. This innovative partnership provides patients with access to evidence-based, clinically validated, and personalized digital therapeutics.
Which Firms Are Making The Biggest Impact In The Generic Musculoskeletal Disorders Drugs Market?
Major companies operating in the generic musculoskeletal disorders drugs market include Pfizer Inc., Sanofi S.A., Eli Lilly and Company, Ampio Pharmaceuticals Inc., Amgen Inc., Boehringer Ingelheim International GmbH, Merck & Co. Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceuticals Industries Ltd., AstraZeneca plc, Mitsubishi Tanabe Pharma Corporation, Horizon Therapeutics plc, Eisai Co. Ltd., Biogen Inc., Sino Biopharmaceutical Limited, Bristol-Myers Squibb Company, Johnson & Johnson Services Inc., AbbVie Inc., Novartis AG, F. Hoffmann-La Roche Ltd., Bayer AG, Mylan Pharmaceuticals Inc., Taisho Pharmaceutical Holdings Co. Ltd., Flexion Therapeutics Inc.
Access The Complete Report Here:
Which Region Is Forecasted To Lead The Generic Musculoskeletal Disorders Drugs Market In The Coming Years?
Asia-Pacific was the largest region in the generic musculoskeletal disorders drugs market in 2024. The regions covered in the generic musculoskeletal disorders drugs market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=9433&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
